Galanin and galanin message-associated peptide (GMAP) synthesis is up-regulated in neurons and glial cells in the adult rat brain by different experimental manipulations, including intracerebroventricular colchicine. We have previously reported that the galanin expression is severely attenuated in some neurons in adult hypothyroidism. In order to further investigate the role of thyroid hormone for the in vivo regulation of galanin gene expression, we have studied the effect of intraventricular administration of colchicine on prepro-galanin (ppGAL) mRNA expression in the brain of normal and hypothyroid, adult male rats. While ppGAL mRNA levels were markedly elevated in a great number of glial cells in the white and gray matter in normal rats, this effect was almost completely abolished in hypothyroid rats. In contrast, colchicine-induced up-regulation of galanin/GMAP expression occurs in the hypothalamic paraventricular nucleus both of euthyroid and hypothyroid rats, although with a slightly different time course.

Keywords:
Colchicine, Galanin, Glial cells, In situ hybridization, Paraventricular nucleus, Thyroid hormone
1.
Tatemoto K, Rökaeus A, Jörnvall H, McDonald TJ, Mutt V: Galanin – A novel biologically active peptide from porcine intestine. FEBS Lett 1993;164:124–128.
2.
Rökaeus Å, Melander T, Hökfelt T, Lundberg J, Tatemoto K, Carlquist M, Mutt V: A galanin-like peptide in the central nervous system and intestine of the rat. Neurosci Lett 1984;47:161–166.
3.
Skofitsch G, Jacobowitz DM: Immunohistochemical mapping of galanin-like neurons in the rat central nervous system. Peptides 1985;6:509–546.
4.
Melander T, Hökfelt T, Rökaeus A: Distribution of galanin-like immunoreactivity in the rat central nervous system. J Comp Neurol 1986;48:475–517.
5.
Xu Z, Cortes R, Villar M, Molino P, Castel MN, Hökfelt T: Evidence for up-regulation of galanin synthesis in rat glial cells in vivo after colchicine. Neurosci Lett 1992;145:185–188.
6.
Bauer FE, Ginsberg L, Venetikou M, MacKay DJ, Burrin JM, Bloom SR: Growth hormone release in man induced by galanin, a new hypothalamic peptide. Lancet 1986;ii:192–195.
7.
Leibowitz SF: Brain peptide and obesity: Pharmacological treatments. Obes Res 1995;3 (suppl 4):573S–589S.
8.
Wiesenfeld-Hallin Z, Bartfai T, Hökfelt T: Galanin in sensory neurons in the spinal cord. Front Neuroendocrinol 1992;13:319–343.
9.
Crawley JN: Minireview. Galanin-acetylcholine interactions: Relevance for memory and Alzheimer’s disease. Life Sci 1996;58:2185–2199.
10.
Chan-Palay V: Galanin hyperinnervate surviving neurons of the human basal nucleus of Meynert in dementia of Alzheimer’s type and Parkinson’s disease: A hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. J Comp Neurol 1988;273:543–557.
11.
Habert-Ortoli E, Amiranoff B, Loquet I, Laburthe M, Mayaux JF: Molecular cloning of a functional human galanin receptor. Proc Natl Acad Sci USA 1994;91:9780–9783.
12.
Burgevin MC, Loquet I, Quarteronet D, Habert-Ortoli E: Cloning, pharmacological characterization and anatomical distribution of a rat cDNA encoding for a galanin receptor. J Mol Neurosci 1995;6:33–41.
13.
Howard AD, Tan C, Shiao LL, Palyha OC, McKee KK, Wainberg DH, Feighner SD, Cascieri MA, Smith RG, Van der Ploeg LH, Sullivan KA: Molecular cloning of a new receptor for galanin. FEBS Lett 1997;405:285–290.
14.
Parker EM, Izzarelli DG, Nowak HP, Mahle CD, Iben LG, Wang J, Goldstein ME: Cloning and characterization of the rat GALR1 galanin receptor from Rin 14B insulinoma cells. Mol Brain Res 1995;34:179–189.
15.
Wang S, He C, Hashemi T, Bayne M: Cloning and expressional characterization of a novel galanin receptor. J Biol Chem 1997;272:31949–31952.
16.
Wang S, Hashemi T, He C, Strader C, Bayne M: Molecular cloning and pharmacological characterization of a new galanin receptor subtype. Mol Pharmacol 1997;52:337–343.
17.
Fathi Z, Cunningham AM, Iben LG, Battaglini PB, Ward SA, Nichol KA, Pine KA, Wang J, Goldstein ME, Iismaa TP, Zimanyi IA: Cloning, pharmacological characterization and distribution of a novel galanin receptor. Mol Brain Res 1997;51:49–59.
18.
Mitchell V, Habert-Ortoli E, Epelbaum J, Aubert JP, Beauvillain JC: Semiquantitative distribution of galanin-receptor (GAL-R1) mRNA-containing cells in the male rat hypothalamus. Neuroendocrinology 1997;66:160–172.
19.
Hösli E, Ledergerber M, Kofler A, Hösli L: Evidence for the existence of galanin receptors on cultured astrocytes of rat CNS: Colocalization with cholinergic receptors. J Chem Neuroanat 1997;13:95–103.
20.
Vrontakis ME, Peden LM, Duckworth ML, Frieses HG: Isolation and characterization of a complementary DNA (galanin) clone from estrogen-induced pituitary tumor messenger RNA. J Biol Chem 1987;262:16755–16758.
21.
Kaplan LM, Gabriel SM, Koenig JI, Sunday ME, Spinder ER, Martin JB, Chin WW: Galanin is an estrogen-inducible, secretory product of the rat anterior pituitary. Proc Natl Acad Sci USA 1988;85:7408–7412.
22.
Planas B, Kolb PE, Raskind MA, Miller MA: Galanin gene expression declines with adulthood in the cholinergic fields of the horizontal diagonal band of male rats. Brain Res 1996;728:57–64.
23.
Hooi SC, Koenig JI, Gabriel SM, Maiter D, Martin JB: Influence of thyroid hormone on the concentration of galanin in the rat brain and pituitary. Neuroendocrinology 1990;51:351–356.
24.
Giardino L, Velardo A, Gallinelli A, Calzà L: Deficit of galanin-like immunostaining in the median eminence of adult hypothyroid rats. Neuroendocrinology 1992;55:237–247.
25.
Selvais PL, Colin IM, Adam E, Kasa-Vuba JZ, Denef JF, Maiter DM: Effects of hypophysectomy on galaninergic neurons in the rat hypothalamus. Neuroendocrinology 1993;58:539–547.
26.
Ceccatelli S, Giardino L, Calzà L: Response of hypothalamic peptide mRNAs to thyroidectomy. Neuroendocrinology 1992;56:694–703.
27.
Calzà L, Giardino L, Aloe L: Thyroid hormone-induced plasticity in the adult rat brain. Brain Res Bull 1997;44:549–557.
28.
Hooi SC, Koenig JI, Abraczinskas DR, Kaplan LM: Regulation of anterior pituitary galanin gene expression by thyroid hormone. Mol Brain Res 1997;51:15–22.
29.
Rökaues A, Brownstein MJ: Construction of a porcine adrenal medullary cDNA library and nucleotide sequence analysis of two clones encoding a galanin precursor. Proc Natl Acad Sci USA 1986;83:6287–6291.
30.
Dahlström A: Effect of colchicine on transport of amine storage granules in sympathetic nerves of rat. Eur J Pharmacol 1968;5:111–113.
31.
Kreutzberg GW: Neuronal dynamics and axonal flow. IV. Blockade of intra-axonal enzyme transport by colchicine. Proc Natl Acad Sci USA 1969;62:722–728.
32.
Cortes R, Ceccatelli S, Shalling M, Hökfelt T: Differential effects of intracerebroventricular colchicine administration on the expression of mRNAs for neuropeptides and neurotransmitters enzymes, with special emphasis on galanin: An in situ hybridization study. Synapse 1990;6:369–391.
33.
Dagerlind A-J, Friberg K, Bean A, Hökfelt T: Sensitive mRNA detection using unfixed tissue: Combined radioactive and non-radioactive in situ hybridization histochemistry. Histochemistry 1992;98:39–49.
34.
Kofler B, Evans HF, Liu ML, Falls V, Iismaa TP, Shine J, Herzog H: Characterization of the 5′-flanking region of the human preprogalanin gene. DNA Cell Biol 1995;14:321–329.
35.
Rökaeus A, Washek JA: Primary sequence and functional analysis of the bovine galanin gene promoter in human neuroblastoma cells. DNA Cell Biol 1994;13:845–855.
36.
Corness J, Burbach JP, Hökfelt T: The rat galanin-gene promoter: Response to members of the nuclear hormone receptor family, phorbol ester and foskolin. Mol Brain Res 1997;47:11–23.
37.
Sap J, Munoz A, Damm K, Goldberg Y, Ghysdael J, Leuts A, Beug H, Vennström B: The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature 1986;324:635–640.
38.
Koenig RJ, Warne RL, Brant GA, Harney JW, Larsen PR, Moore DD: Isolation of a cDNA clone encoding a biologically active thyroid hormone receptor. Proc Natl Acad Sci USA 1988;85:5031–5035.
39.
Lazar MA: Thyroid hormone receptors: Multiple forms, multiple possibilities. Endocr Rev 1993;14:184–193.
40.
Puymirat J, Miehe M, Marchand R, Sarlieve L, Dussault JH: Immunocytochemical localization of thyroid hormone receptors in the adult rat brain. Thyroid 1991;1:173–184.
41.
Bradley DJ, Young WS, Weinberger C: Differential expression of alpha and beta thyroid hormone receptor genes in rat brain and pituitary. J Neurosci 1989;86:7250–7254.
42.
Leonard JL, Farwell AP, Yen PM, Chin WW, Stula M: Differential expression of thyroid hormone receptor isoforms in neurons and astroglial cells. Endocrinology 1994;135:548–555.
43.
Fierro-Renoy JF, Szuchet S, Falcone M, Macchia E, DeGroot L: Three different thyroid hormone receptor isoforms are detected in a pure culture of ovine oligodendrocytes. Glial 1995;14:322–328.
44.
Garcia-Segura LM, Chowen JA, Naftolin F: Endocrine glia: Roles of glial cells in the brain actions of steroid and thyroid hormones and in the regulation of hormone secretion. Front Neuroendocrinol 1996;17:180–211.
45.
Sherline P, Leung JT, Kipnis DM: Binding of colchicine to purified microtubule protein. J Biol Chem 1975;250:5481–5486.
46.
D’Amato RJ, Lin CM, Flynn E, Folkman J, Hamel E: 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc Natl Acad Sci USA 1994;91:3964–3968.
47.
Aniello F, Couchie D, Gripois D, Nunez J: Regulation of five tubulin isotypes by thyroid hormone during brain development. J Neurochem 1991;57:1781–1786.
48.
Nunez J, Couchie D, Aniello F, Bridoux AM: Regulation by thyroid hormone of microtubule assembly and neuronal differentiation. Neurochem Res 1991;16:975–982.
49.
Poddar P, Paul S, Chaudhury S, Sarkar PK: Regulation of actin and tubulin gene expression by thyroid hormone during brain development. Mol Brain Res 1996;35:111–118.
50.
Stein SA, Kirkpatrick LL, Shanklin DR, Adams PM, Brady ST: Hypothyroidism reduces the rate of slow component A (Sca) axonal transport and the amount of transported tubulin in the hyt/hyt mouse optic nerve. J Neurosci Res 1991;28:121–133.
51.
Silva JE, Rudas P: Effects of congenital hypothyroidism on microtubule-associated protein 2 expression in the cerebellum of the rat. Endocrinology 1990;126:1276–1282.
52.
De A, Chaudhury S, Sarkar PK: Thyroidal stimulation of tubulin and actin in primary cultures of neuronal and glial cells of the rat brain. Int J Dev Neurosci 1991;9:381–390.
53.
Calzà L, Giardino L, Ceccatelli S, Hökfelt T: Neurotrophins and their receptors in the adult hypo- and hyperthyroid rat after kainic acid injection: An in situ hybridization study. Eur J Neurosci 1996;8:1873–1881.
54.
Ceccatelli S, Villar MJ, Goldstein M, Hökfelt T: Expression of c-Fos immunoreactivity in transmitter-characterized neurons after stress. Proc Natl Acad Sci USA 1989;86:9569–9573.
55.
Shuaib A, Ijaz S, Mazagri R, Kalra J, Hemmings S, Senthilsylvan A, Crosby N: Hypothyroidism protects the brain during transient forebrain ischemia in gerbils. Exp Neurol 1994;127:119–125.
56.
Shuaib A, Ijaz S, Hemmings S, Galazka P, Ishaqzay R, Liu L, Ravindran J, Miyashita H: Decreased glutamate release during hypothyroidism may contribute to protection in cerebral ischemia. Exp Neurol 1994;128:260–265.
57.
Giardino L, Ceccatelli S, Hökfelt T, Calzà L: Expression of enkephalin and dynorpin precursor mRNAs in brain areas of hypo- and hyperthyroid rats: Effect of kaininc acid injection. Brain Res 1995;687:83–93.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.